Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancer
Ning An, Haoyi Wang, Wenxiao Jia, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM
Aizhen Xiong, Jiwei Zhang, Yan Chen, et al.
EBioMedicine (2022) Vol. 83, pp. 104239-104239
Open Access | Times Cited: 48
CD4+ T cells in antitumor immunity
Elena Montauti, David Y. Oh, Lawrence Fong
Trends in cancer (2024)
Open Access | Times Cited: 10
Recent Progress in the Synergistic Combination of Nanoparticle‐Mediated Hyperthermia and Immunotherapy for Treatment of Cancer
Zachary R. Stephen, Miqin Zhang
Advanced Healthcare Materials (2020) Vol. 10, Iss. 2
Open Access | Times Cited: 52
Benzo[a]pyrene immunogenetics and immune archetype reprogramming of lung
Eslam E. Abd El-Fattah, A. M. Abdelhamid
Toxicology (2021) Vol. 463, pp. 152994-152994
Closed Access | Times Cited: 37
Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index
Man Zhao, Xiaoling Duan, Lili Mi, et al.
Future Oncology (2022) Vol. 18, Iss. 18, pp. 2269-2288
Closed Access | Times Cited: 22
Immune Modulation in Lung Cancer: Current Concepts and Future Strategies
Lena Gaissmaier, Petros Christopoulos
Respiration (2020) Vol. 99, Iss. 11, pp. 903-929
Open Access | Times Cited: 23
Effect of chemoradiotherapy on the proportion of circulating lymphocyte subsets in patients with limited-stage small cell lung cancer
Yamei Chen, Ying Jin, Xiao Hu, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 10, pp. 2867-2876
Open Access | Times Cited: 13
A Novel Prognostic Score Based on Artificial Intelligence in Hepatocellular Carcinoma: A Long-Term Follow-Up Analysis
Xiaoli Liu, Xinhui Wang, Lihua Yu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer
Ashish Saxena
Seminars in Cancer Biology (2023) Vol. 90, pp. 45-56
Closed Access | Times Cited: 5
On the Prognostic Power of Tumor-Infiltrating Lymphocytes – A Critical Commentary
Zeev Elkoshi
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Elicitation of stem-like CD8+T cell responses via lymph node-targeted chemoimmunotherapy evokes systemic tumor control
Margaret P. Manspeaker, Meghan J. O’Melia, Susan N. Thomas
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e005079-e005079
Open Access | Times Cited: 8
Prognostic value of peripheral blood T lymphocyte subsets in clear cell renal cell carcinoma
Yihong Zhou, Dong Jiang, Xi Chu, et al.
Translational Andrology and Urology (2021) Vol. 10, Iss. 1, pp. 326-335
Open Access | Times Cited: 11
Selective Internal Radiotherapy Changes the Immune Profiles of Extracellular Vesicles and Their Immune Origin in Patients with Inoperable Cholangiocarcinoma
Florian Haag, Anjana Manikkam, Daniel Kraft, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2309-2309
Open Access | Times Cited: 7
Prognostic value of H‐index in patients surgically treated for squamous cell carcinoma of the larynx
Paolo Boscolo‐Rizzo, Enrico Zanelli, Fabiola Giudici, et al.
Laryngoscope Investigative Otolaryngology (2021) Vol. 6, Iss. 4, pp. 729-737
Open Access | Times Cited: 9
T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani
Cellular Immunology (2022) Vol. 377, pp. 104554-104554
Closed Access | Times Cited: 6
Developing an Immune Signature for Triple-Negative Breast Cancer to Predict Prognosis and Immune Checkpoint Inhibitor Response
Ce Wang, Guoshuang Feng, Jingjing Zhu, et al.
Future Oncology (2022) Vol. 18, Iss. 9, pp. 1055-1066
Closed Access | Times Cited: 5
CT-based radiomics signature to predict CD8+ tumor infiltrating lymphocytes in non-small-cell lung cancer
Yaxi Chen, Ting Xu, Changsi Jiang, et al.
Acta Radiologica (2022) Vol. 64, Iss. 4, pp. 1390-1399
Closed Access | Times Cited: 5
Circulating tumor cells counts are associated with CD8+ T cell levels in programmed death-ligand 1-negative non-small cell lung cancer patients after radiotherapy
Qingyun Liu, Chaoren Zhao, Penghui Jiang, et al.
Medicine (2021) Vol. 100, Iss. 29, pp. e26674-e26674
Open Access | Times Cited: 7
Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer
Zhihui Zhang, Peng Wu, Chaoqi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 5
[Immune Characteristics of Small Cell Lung Cancer].
Yan Zhu, Shikai Wu
DOAJ (DOAJ: Directory of Open Access Journals) (2020) Vol. 23, Iss. 10, pp. 889-896
Closed Access | Times Cited: 4
Analysis of Circulating Tumor and Cancer Stem Cells Provides New Opportunities in Diagnosis and Treatment of Small Cell Lung Cancer
Е. G. Skurikhin, Н. Н. Ермакова, М. А. Zhukova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10853-10853
Open Access | Times Cited: 3
Peripheral Blood CD8+T Cell as a Prognostic Biomarker for Hospitalised COVID-19 Patients Without Antiviral Treatment
Yuming Sun, Peilin Liu, Lifang Zhang, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 109-117
Open Access
IFN-Type-I Response and Systemic Immunity in Rectal Adenocarcinoma Patients Treated with Conventional or Hypofractionated Neoadjuvant Radiotherapy
Ioannis M. Koukourakis, Erasmia Xanthopoulou, Michael I. Koukourakis, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 448-448
Open Access
A first‐in‐class, first‐in‐human, phase I trial of CIGB‐552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF‐κB in patients with advanced solid tumors
Maribel Guerra Vallespí, Braulio Mestre, Maria A. Marrero, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 6, pp. 1313-1321
Open Access | Times Cited: 3
Mathematical Model of a Personalized Neoantigen Cancer Vaccine and the Human Immune System: Evaluation of Efficacy
Marisabel Rodriguez Messan, Osman N. Yoğurtçu, Joseph R. McGill, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top